Two of the key proteins implicated in pathological aggregation in AD, beta-amyloid (Aβ) [2, 3] and tau [4–6], are physiologically released during synaptic activity, making efficient clearance potentially essential to prevent neurotoxic accumulation. Here, MAPT is linked to Alzheimer disease.